Hematologia Geral

Série de casos | Trombocitopenia induzida por vacina com cefaleia grave pode preceder uma trombose sinusal venosa cerebral em vários dias – Pacientes com cefaleia grave 5 a 20 dias depois de tomarem vacina com vetor de adenovírus contra Covid-19 devem relizar teste para trombocitopenia e níveis de D-dímero e, se disponível, teste para anticorpo anti-PF4-heparina IgG.

17 Set, 2021 | 12:44h

Vaccine-Induced Thrombocytopenia with Severe Headache – New England Journal of Medicine

Comentário no Twitter

Experience with 11 patients suggests that elements of VITT (severe headache, elevated d-dimer levels, and positivity for anti-PF4 antibodies) after ChAdOx1 nCoV-19 vaccination may precede VITT. #Covid19Vaccines #COVID19 #SARSCoV2 #IDTwitter https://t.co/mzBgjJIE6l pic.twitter.com/wGqb1gKFXk

— NEJM (@NEJM) September 15, 2021

Revisão do Estado de Arte | Eosinofilia na saúde e na doença.

17 Set, 2021 | 12:31h

Eosinophils in Health and Disease: A State-of-the-Art Review – Mayo Clinic Proceedings

Revisão | Existe uma estratégia antiplaquetária ótima após sangramento gastrintestinal em pacientes com doença arterial coronariana?

17 Set, 2021 | 12:29h

Is There an Optimal Antiplatelet Strategy after Gastrointestinal Bleeding in Patients with Coronary Artery Disease? – Cardiology

M-A | Estudo mostra risco significativo de sangramento maior durante terapia de anticoagulação oral estendida após primeira ocorrência de tromboembolismo venoso não provocado.

14 Set, 2021 | 14:21h

Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis – Annals of Internal Medicine (link para o resumo – $ para o texto completo)

Comentários:

Long-term Anticoagulation After Unprovoked VTE: New Insights – TCTMD

Extended Anticoagulation Tied to Major Bleeding Risk – HealthDay

Comentário no Twitter

🆕 Delighted to share the MAJESTIC Study providing best available estimates for major bleeding risk during extended #anticoagulation of up to 5 years in patients with unprovoked #VTE (& clinically important subgroups), now published in @AnnalsofIM!https://t.co/Ri2EvZvffq pic.twitter.com/3jvN8mTKSi

— Faizan Khan (@FaizanK91) September 13, 2021

Diretriz para o tratamento da anemia por deficiência de ferro em adultos.

12 Set, 2021 | 22:10h

British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults – Gut

Estudo randomizado | Plasma convalescente não melhora os desfechos e pode ser prejudicial a pacientes hospitalizados com COVID-19.

12 Set, 2021 | 21:56h

Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial – Nature Medicine

Comunicado de imprensa: Major study finds convalescent plasma doesn’t help seriously ill COVID-19 patients – McMaster University

Conteúdos relacionados:

NIH study shows no significant benefit of convalescent plasma for COVID-19 outpatients with early symptoms.

M-A: Convalescent plasma is safe but does not improve outcomes in the treatment of COVID-19.

RECOVERY Trial: No benefit from convalescent plasma in patients admitted to hospital with COVID-19.

Comentário no Twitter

A randomized trial in patients hospitalized with COVID-19 showed no benefit and potentially increased harm associated with the use of convalescent plasma, according to a @NatureMedicine paper. https://t.co/7JFhEXLmbA pic.twitter.com/Q3e50Q0I7T

— Nature Portfolio (@NaturePortfolio) September 9, 2021